Single and multi-dose studies of the small molecule TREM2 agonist VG-3927 clear early safety hurdle. Meanwhile, new findings ...

Lasmiditan is a promising treatment for menstrual migraine, offering sustained pain relief comparable to or exceeding that of triptans. However, further research is needed to fully assess its safety ...

Among the group that did no monthly exercise, 5 percent of participants had low headache frequency (four or fewer headaches per month), with 48 percent reporting high frequency. In the high ...